182 related articles for article (PubMed ID: 18383900)
1. Prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Papadoniou N; Kosmas C; Gennatas K; Polyzos A; Mouratidou D; Skopelitis E; Tzivras M; Sougioultzis S; Papastratis G; Karatzas G; Papalambros E; Tsavaris N
Anticancer Res; 2008; 28(1B):543-9. PubMed ID: 18383900
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.
Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW
Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768
[TBL] [Abstract][Full Text] [Related]
3. CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kosmas C; Papadoniou N; Kopterides P; Tsigritis K; Dokou A; Sarantonis J; Skopelitis H; Tzivras M; Gennatas K; Polyzos A; Papastratis G; Karatzas G; Papalambros A
J Chemother; 2009 Dec; 21(6):673-80. PubMed ID: 20071292
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response.
Tingstedt B; Johansson P; Andersson B; Andersson R
Scand J Gastroenterol; 2007 Jun; 42(6):754-9. PubMed ID: 17505998
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first-line palliative chemotherapy.
Park I; Lee JL; Ryu MH; Kim TW; Sook Lee S; Hyun Park D; Soo Lee S; Wan Seo D; Koo Lee S; Kim MH
Cancer; 2009 Sep; 115(18):4148-55. PubMed ID: 19536892
[TBL] [Abstract][Full Text] [Related]
8. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline.
Fujino Y; Suzuki Y; Ajiki T; Tanioka Y; Ku Y; Kuroda Y
Hepatogastroenterology; 2003; 50(49):250-3. PubMed ID: 12630033
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials.
Cubiella J; Castells A; Fondevila C; Sans M; Sabater L; Navarro S; Fernández-Cruz L
Am J Gastroenterol; 1999 May; 94(5):1271-8. PubMed ID: 10235206
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
Chang DT; Schellenberg D; Shen J; Kim J; Goodman KA; Fisher GA; Ford JM; Desser T; Quon A; Koong AC
Cancer; 2009 Feb; 115(3):665-72. PubMed ID: 19117351
[TBL] [Abstract][Full Text] [Related]
12. The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer.
Kang CM; Kim JY; Choi GH; Kim KS; Choi JS; Lee WJ; Kim BR
J Surg Res; 2007 Jun; 140(1):31-5. PubMed ID: 17418869
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis.
Tsavaris N; Kavantzas N; Tsigritis K; Xynos ID; Papadoniou N; Lazaris A; Kosmas C; Agrogiannis G; Dokou A; Felekouras E; Antoniou E; Polyzos A; Sarantonis J; Tsipras H; Karatzas G; Papalambros A; Patsouris ES
BMC Cancer; 2009 Jul; 9():264. PubMed ID: 19646258
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-molecular-weight heparin on survival in patients with advanced pancreatic adenocarcinoma.
von Delius S; Ayvaz M; Wagenpfeil S; Eckel F; Schmid RM; Lersch C
Thromb Haemost; 2007 Aug; 98(2):434-9. PubMed ID: 17721628
[TBL] [Abstract][Full Text] [Related]
15. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC; Iott MJ; Corsini MM
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.
Waraya M; Yamashita K; Katagiri H; Ishii K; Takahashi Y; Furuta K; Watanabe M
Ann Surg Oncol; 2009 May; 16(5):1231-40. PubMed ID: 19263172
[TBL] [Abstract][Full Text] [Related]
17. Predictors of systemic chemotherapy contraindication in pancreatic cancer patients with distant metastasis.
Zhang Y; Dang C; Ma Q; Chen W; Nagata K
Hepatogastroenterology; 2007; 54(73):254-9. PubMed ID: 17419272
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
Corsini MM; Miller RC; Haddock MG; Donohue JH; Farnell MB; Nagorney DM; Jatoi A; McWilliams RR; Kim GP; Bhatia S; Iott MJ; Gunderson LL
J Clin Oncol; 2008 Jul; 26(21):3511-6. PubMed ID: 18640932
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for long-term survival in patients with locally invasive pancreatic cancer.
Tani M; Kawai M; Terasawa H; Ina S; Hirono S; Shimamoto T; Miyazawa M; Uchiyama K; Yamaue H
J Hepatobiliary Pancreat Surg; 2007; 14(6):545-50. PubMed ID: 18040618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
